Sanofi Genzyme starts phase 3 trial of second-generation enzyme replacement therapy for Pompe diseas
Sanofi Genzyme, the specialty care global business unit of Sanofi, has started a pivotal Phase 3 clinical trial named COMET for the investigational therapy neoGAA for Pompe Disease.
